Filing Details

Accession Number:
0001264124-11-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-15 17:30:35
Reporting Period:
2011-01-18
Filing Date:
2011-02-15
Accepted Time:
2011-02-15 17:30:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881464 Amylin Pharmaceuticals Inc AMLN Pharmaceutical Preparations (2834) 330266089
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1220966 Iii R James Gavin 9360 Towne Centre Dr
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-18 2,251 $14.94 2,251 No 4 X Direct
Common Stock Disposition 2011-01-18 671 $14.94 1,580 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Phantom Stock-Deferred Compensation Disposition 2011-01-18 2,251 $14.94 2,251 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,536 No 4 X Direct
Footnotes
  1. Represents a previously elected in-service withdrawal from Amylin's Deferred Compensation Plan.
  2. Sale of common shares to satisfy reporting person's income tax withholding obligations.
  3. The shares of phantom stock will be distributed to the reporting person in the form of Amylin common stock in a lump sum six months following the date on which the reporting person no longer serves on Amylin's Board of Directors.